NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 127 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $211,827 | +77.3% | 133,225 | -4.2% | 0.00% | – |
Q4 2023 | $119,478 | -19.8% | 139,090 | -0.0% | 0.00% | – |
Q3 2023 | $148,886 | -58.8% | 139,145 | -0.3% | 0.00% | – |
Q2 2023 | $361,398 | -33.2% | 139,536 | +5.2% | 0.00% | – |
Q1 2023 | $541,391 | -19.2% | 132,694 | -0.5% | 0.00% | – |
Q4 2022 | $669,743 | -66.0% | 133,415 | -11.4% | 0.00% | – |
Q3 2022 | $1,970,000 | +17.5% | 150,629 | +15.2% | 0.00% | – |
Q2 2022 | $1,677,000 | -17.0% | 130,789 | -1.3% | 0.00% | – |
Q1 2022 | $2,021,000 | -11.3% | 132,514 | +3.0% | 0.00% | – |
Q4 2021 | $2,278,000 | -7.6% | 128,621 | +9.7% | 0.00% | – |
Q3 2021 | $2,465,000 | +23.2% | 117,234 | +15.6% | 0.00% | – |
Q2 2021 | $2,000,000 | -13.7% | 101,391 | +27.1% | 0.00% | – |
Q1 2021 | $2,318,000 | -8.0% | 79,756 | -4.1% | 0.00% | -100.0% |
Q4 2020 | $2,519,000 | +86.2% | 83,155 | -2.2% | 0.00% | – |
Q3 2020 | $1,353,000 | -15.6% | 85,046 | +4.8% | 0.00% | – |
Q2 2020 | $1,603,000 | +57.9% | 81,189 | -1.3% | 0.00% | – |
Q1 2020 | $1,015,000 | -6.5% | 82,295 | +40.1% | 0.00% | – |
Q4 2019 | $1,085,000 | +214.5% | 58,728 | +135.5% | 0.00% | – |
Q3 2019 | $345,000 | +96.0% | 24,937 | +107.7% | 0.00% | – |
Q2 2019 | $176,000 | – | 12,009 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|